| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| BBT-877 | BBT-877 | Phase 2 Clinical | Legochem | Idiopathic Pulmonary Fibrosis | 상세 |
| Cambritaxestat | CRT-0273750; IOA-289 | Phase 2 Clinical | Cancer Research Technology, Merck & Co | Pancreatic Neoplasms; Solid tumours | 상세 |
| HRS-9813 | HRS-9813; HRS9813 | Phase 2 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | 상세 |
| HW-021199 | HW-021199 | Phase 2 Clinical | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc, Humanwell Puracap (Likang) Pharmaceuticals Co Ltd | Idiopathic Pulmonary Fibrosis | 상세 |
| HNC664 | HNC664; HNC-664 | Phase 1 Clinical | Guangzhou Henovcom Bioscience Co Ltd | Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms | 상세 |
| Cudetaxestat | PAT-409; BLD-0409 | Phase 1 Clinical | Blade Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Liver Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease | 상세 |
| NXC-680 | NXC-680 | Phase 1 Clinical | Nextgen Bioscience Inc | Idiopathic Pulmonary Fibrosis | 상세 |
| HNC-1058 | HNC-1058 | Phase 1 Clinical | Guangzhou Henovcom Bioscience Co Ltd | Idiopathic Pulmonary Fibrosis | 상세 |
| FTP-198 | FTP-198 | Phase 1 Clinical | Haisco Pharmaceutical Group Co Ltd | Idiopathic Pulmonary Fibrosis | 상세 |